A validated stability-indicating normal phase LC method for clopidogrel bisulfate and its impurities in bulk drug and pharmaceutical dosage form

Journal of Pharmaceutical and Biomedical Analysis

Volumn 52, Issue 1, 2010, Pages 160-165

  Durga Rao, Dantu ^a   Kalyanaraman, L ^a   Sait, Shakil S ^a   Venkata Rao, P ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

Author keywords

Clopidogrel bisulfate; Development; Impurities; Normal phase liquid chromatography; Stability indicating

Indexed keywords

ALCOHOL; CLOPIDOGREL; DIETHYLAMINE; HEXANE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG IMPURITY; DRUG STRUCTURE; HYDROLYSIS; LIQUID CHROMATOGRAPHY; OXIDATION; PHOTODEGRADATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

CALIBRATION; CHROMATOGRAPHY, LIQUID; DRUG CONTAMINATION; DRUG STABILITY; FIBRINOLYTIC AGENTS; GUIDELINES AS TOPIC; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; ISOMERISM; OXIDATION-REDUCTION; PHOTOLYSIS; PLATELET AGGREGATION INHIBITORS; REPRODUCIBILITY OF RESULTS; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TICLOPIDINE;

EID: 74249104641     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.12.027     Document Type: Article

References (16)

1. Richter T., Mürdter T.E., Heinkele G., Poleis J., Tatzel S., Schwab M., Eichelbaum M., and Zanger U.M. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine. J. Pharmacol. Exp. Ther. 308 (2004) 189-197
2. Pereillo J.M., Maftouh M., Andrieu A., Uzabiaga M.F., Fedeli O., Savi P., Pascal M., Herbert J.M., Maffarand J.P., and Picard C. Structure and stereochemistry of the active metabolite of clopidogrel. Drug Metab. Dispos. 30 (2002) 1288-1295
3. United States Pharmacopeia. The United States Pharmacopeial Convention (2005), United States Pharmacopeia, Rockville, MD, USA pp. 516-517
4. Mishara P., and Dolly A. RP-HPLC analysis of aspirin and clopidogrel bisulphate in combination. Indian J. Pharm. Sci. 67 (2005) 491-493
5. Mishara P., and Dolly A. Simultaneous determination of clopidogrel and aspirin in pharmaceutical dosage forms. Indian J. Pharm. Sci. 68 (2006) 365-368
6. Mitakos A., and Panderi I. A validated LC method for the determination of clopidogrel in pharmaceutical preparations. J. Pharm. Biomed. Anal. 28 (2002) 431-438
7. Aboul-Enein H.Y., Hoenen H., Ghanem A., and Koll M. Reversed phase liquid chromatographic method for the high-throughput analysis of clopidogrel in pharmaceutical formulations using a monolithic silica column. J. Liq. Chromatogr. Relat. Technol. 28 (2005) 1357-1365
8. Fayeda A.S., Weshahy S.A., Shehata M.A., Hassan N.Y., Pauwels J., Hoogmartens J., and Schepdael A.V. Separation and determination of clopidogrel and its impurities by capillary electrophoresis. J. Pharm. Biomed. Anal. 49 (2009) 193-200
9. Agrawal H., Kaul N., Paradkar A.R., and Mahadik K.R. Stability indicating HPTLC determination of clopidogrel bisulphate as bulk drug and in pharmaceutical dosage form. Talanta 61 (2003) 581-586
10. Robinson A., Hillis J., Neal C., and Leary A.C. The validation of a bioanalytical method for the determination of clopidogrel in human plasma. J. Chromatogr. B 848 (2007) 344-347
11. Gomez Y., Adams E., and Hoogmartens J. Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand. J. Pharm. Biomed. Anal. 34 (2004) 341-348
12. Lagorce P., Perez Y., Ortiz J., Necciari J., and Bressolle F. Assay method for the carboxylic acid metabolite of clopidogrel in human plasma by gas chromatography-mass spectrometry. J. Chromatogr. B. Biomed. Sci. Appl. 720 (1998) 107-117
13. Ksycinska H., Rudzki P., and Bukowsk-Kiliszek M. Determination of clopidogrel metabolite (SR26334) in human plasma by LC-MS. J. Pharm. Biomed. Anal. 41 (2006) 533-539
14. Souri E., Jalalizadeh H., Kebriaee-Zadeh A., Shekarchi M., and Dalvandi A. Validated HPLC method for determination of carboxylic acid metabolite of clopidogrel in human plasma and its application to a pharmacokinetic study. Biomed. Chromatogr. 20 (2006) 1309-1314
15. ICH. Validation of Analytical Procedures: Text and Methodology (Q2(R1)): International Conference on Harmonization. IFPMA, Geneva (2005)
16. ICH. Stability Testing of New Drug Substances and Products (Q1AR): International Conference on Harmonization. IFPMA, Geneva (2000)